The present invention relates to a method of treating cancer in a human and to pharmaceutical combinations useful in such treatment. In particular , the method relates to a cancer treatment method that includes administering 5- [[4- [(2 ,3 -dimethyl- 2H- indazol- 6- yl)methylamino]- 2- pyrimidinyl]amino]- 2- methylbenzenesulfonamide, or a pharmaceutically acceptable salt thereof , and N- {(1S)- 2 -amino- 1 -[(3, 4- difluorophenyl)methyl]ethyl}- 5- chloro- 4- (4 -chloro- 1 -methyl -1Z/- pyrazol- 5- yl)- 2- furancarboxamide, or a pharmaceutically acceptable salt thereof , to a human in need thereof.
